Nina Garcia
Medical · Columbia, MDNPI 1508926817
Payments from drug & device makers
Across 655 payments — averaging $24.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$5K
- AbbVie$2K
- Johnson & Johnson$1K
- UCB, Inc.$1K
- Lilly USA, LLC$865
- Pfizer$715
- plus $6K from 25 others
What the payments were for
- Speaking & faculty fees$3,03619%
- Travel & lodging$700%
- Food & beverage$12,50478%
- Education$4993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 51 | $4,573 |
| AbbVie(2 entities) | 101 | $1,734 |
| Johnson & Johnson | 46 | $1,206 |
| UCB, Inc. | 64 | $1,114 |
| Lilly USA, LLC | 27 | $865 |
| Pfizer | 38 | $715 |
| E.r. Squibb & Sons, L.L.C. | 51 | $638 |
| Novartis | 35 | $587 |
| Regeneron Healthcare Solutions, Inc. | 18 | $577 |
| Incyte Corporation | 25 | $511 |
| Dermavant Sciences, Inc. | 39 | $459 |
| Galderma Laboratories, L.p. | 32 | $439 |
| Sun Pharmaceutical Industries Inc. | 19 | $406 |
| Amgen | 18 | $389 |
| Medimetriks Pharmaceuticals, Inc. | 19 | $333 |
| LEO Pharma Inc. | 13 | $275 |
| Arcutis Biotherapeutics, Inc. | 20 | $270 |
| Organon | 11 | $229 |
| Sanofi-aventis U.S. LLC | 3 | $200 |
| Boehringer Ingelheim | 3 | $147 |
| Mayne Pharma Commercial LLC | 5 | $112 |
| Strata Skin Sciences, Inc. | 4 | $83 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $82 |
| EPI Health, LLC | 1 | $40 |
| Journey Medical Corporation | 2 | $32 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Botanix SB Inc | 1 | $14 |
| VYNE Pharmaceuticals Inc. | 1 | $14 |
| Almirall LLC | 1 | $13 |
| Biofrontera Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,108 in reported general payments places this provider in the 95th percentile of 543 medical providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 12 | $249,229 |
| Dupixent PenDupilumab | 32 | $123,228 |
| Tacrolimus | 63 | $9,643 |
| Clobetasol Propionate | 72 | $5,526 |
| Pimecrolimus | 19 | $3,918 |
| Mometasone Furoate | 94 | $1,721 |
| Ketoconazole | 81 | $1,451 |
| Betamethasone Valerate | 55 | $1,347 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 20 | $1,285 |
| Tretinoin | 24 | $1,134 |
| Halobetasol Propionate | 17 | $1,100 |
| Ciclopirox | 26 | $1,021 |
| Triamcinolone Acetonide | 84 | $897 |
| Mupirocin | 82 | $806 |
| Clindamycin Phosphate | 22 | $538 |
Paid to pharmacies, not to this prescriber.
Other medical in Columbia
- Adam SchmucklerColumbia$17K
- Jeffrey FrattaliColumbia$8K
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Kristina TrunnellFrederick$51K
- Karen ScottAnnapolis$49K
- Nicholas WunderAberdeen$40K
- Sarah JamiesonFrederick$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.